105 related articles for article (PubMed ID: 3076601)
1. In vitro augmentation of natural killer activity of peripheral blood cells from cancer patients by a DNA fraction from Mycobacterium bovis BCG.
Mashiba H; Matsunaga K; Tomoda H; Furusawa M; Jimi S; Tokunaga T
Jpn J Med Sci Biol; 1988; 41(5-6):197-202. PubMed ID: 3076601
[TBL] [Abstract][Full Text] [Related]
2. In vitro augmentation of macrophage-activating-factor release from peripheral blood cells of cancer patients by a DNA fraction from Mycobacterium bovis BCG.
Mashiba H; Matsunaga K; Tomoda H; Furusawa M
Jpn J Med Sci Biol; 1990 Aug; 43(4):133-9. PubMed ID: 2126049
[TBL] [Abstract][Full Text] [Related]
3. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.
Shimada S; Yano O; Tokunaga T
Jpn J Cancer Res; 1986 Aug; 77(8):808-16. PubMed ID: 2428798
[TBL] [Abstract][Full Text] [Related]
4. In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG.
Yamamoto S; Kuramoto E; Shimada S; Tokunaga T
Jpn J Cancer Res; 1988 Jul; 79(7):866-73. PubMed ID: 2459094
[TBL] [Abstract][Full Text] [Related]
5. [Commemorative lecture of receiving Imamura Memorial Prize. II. Mode of action of oligonucleotide fraction extracted from Mycobacterium bovis BCG].
Yamamoto S
Kekkaku; 1994 Sep; 69(9):571-4. PubMed ID: 7526022
[TBL] [Abstract][Full Text] [Related]
6. In situ infiltration of natural killer-like cells induced by intradermal injection of the nucleic acid fraction from BCG.
Kuramoto E; Toizumi S; Shimada S; Tokunaga T
Microbiol Immunol; 1989; 33(11):929-40. PubMed ID: 2480510
[TBL] [Abstract][Full Text] [Related]
7. The regulation of natural killer cell activity by splenic nonspecific suppressor cells and its modification in cancer patients.
Yanagawa E; Toge T; Sawamura A; Kegoya Y; Baba N; Hattori T
Jpn J Surg; 1988 Nov; 18(6):660-7. PubMed ID: 2977625
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of natural killer cell-mediated cytotoxicity by lipids extracted from Mycobacterium bovis BCG.
Roozemond RC; Halperin M; Das PK
Clin Exp Immunol; 1985 Dec; 62(3):482-90. PubMed ID: 3910316
[TBL] [Abstract][Full Text] [Related]
9. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin.
Esin S; Batoni G; Pardini M; Favilli F; Bottai D; Maisetta G; Florio W; Vanacore R; Wigzell H; Campa M
Immunology; 2004 May; 112(1):143-52. PubMed ID: 15096193
[TBL] [Abstract][Full Text] [Related]
11. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
12. Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
Pislarasu M; Oproiu A; Taranu D; Herberman RB; Sulica A
Cancer Res; 1988 May; 48(9):2596-603. PubMed ID: 3356020
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer.
Kuwahara Y; Kusugami K; Morise K; Shimokata K
Gastroenterol Jpn; 1987 Aug; 22(4):428-34. PubMed ID: 3117611
[TBL] [Abstract][Full Text] [Related]
14. [Augmentation of NK activity in peripheral blood lymphocytes of cancer patients by intermittent GE-132 administration].
Tanaka N; Ohida J; Ono M; Yoshiwara H; Beika T; Terasawa A; Yamada J; Morioka S; Mannami T; Orita K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1303-6. PubMed ID: 6732257
[TBL] [Abstract][Full Text] [Related]
15. Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes.
Anderson TM; Ibayashi Y; Tokuda Y; Colquhoun SD; Holmes EC; Golub SH
Cancer Res; 1988 Mar; 48(5):1180-3. PubMed ID: 3257716
[TBL] [Abstract][Full Text] [Related]
16. DNA from Mycobacterium bovis bacillus Calmette-Guérin (MY-1) inhibits immunoglobulin E production by human lymphocytes.
Fujieda S; Iho S; Kimura Y; Sunaga H; Igawa H; Sugimoto C; Yamamoto S; Saito H
Am J Respir Crit Care Med; 1999 Dec; 160(6):2056-61. PubMed ID: 10588628
[TBL] [Abstract][Full Text] [Related]
17. Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
Hong WS; Kim CM; Lee JO; Kang TW; Yun TK; Kim CY
Jpn J Clin Oncol; 1990 Mar; 20(1):87-93. PubMed ID: 2108272
[TBL] [Abstract][Full Text] [Related]
18. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells.
Tokunaga T; Yano O; Kuramoto E; Kimura Y; Yamamoto T; Kataoka T; Yamamoto S
Microbiol Immunol; 1992; 36(1):55-66. PubMed ID: 1584073
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.
Tokunaga T; Yamamoto H; Shimada S; Abe H; Fukuda T; Fujisawa Y; Furutani Y; Yano O; Kataoka T; Sudo T
J Natl Cancer Inst; 1984 Apr; 72(4):955-62. PubMed ID: 6200641
[TBL] [Abstract][Full Text] [Related]
20. Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG.
Kawahara M; Hasegawa N; Takaku H
PLoS One; 2016; 11(3):e0152051. PubMed ID: 26999357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
